OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis
María A. López-Olivo, Valeria Valerio, Aliza R. Karpes Matusevich, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1195-1195
Open Access | Times Cited: 18
María A. López-Olivo, Valeria Valerio, Aliza R. Karpes Matusevich, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1195-1195
Open Access | Times Cited: 18
Showing 18 citing articles:
Vaccination of Adults With Cancer: ASCO Guideline
Mini Kamboj, Kari Bohlke, Deana M. Baptiste, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1699-1721
Closed Access | Times Cited: 28
Mini Kamboj, Kari Bohlke, Deana M. Baptiste, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1699-1721
Closed Access | Times Cited: 28
COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Juan Ignacio Ruiz, María A. López-Olivo, Yimin Geng, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006246-e006246
Open Access | Times Cited: 19
Juan Ignacio Ruiz, María A. López-Olivo, Yimin Geng, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006246-e006246
Open Access | Times Cited: 19
The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases
Sruthi Vijaya Retnakumar, Camille Chauvin, Jagadeesh Bayry
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108399-108399
Open Access | Times Cited: 16
Sruthi Vijaya Retnakumar, Camille Chauvin, Jagadeesh Bayry
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108399-108399
Open Access | Times Cited: 16
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
Paolo Pedrazzoli, Angioletta Lasagna, Irene Cassaniti, et al.
ESMO Open (2023) Vol. 8, Iss. 3, pp. 101215-101215
Open Access | Times Cited: 12
Paolo Pedrazzoli, Angioletta Lasagna, Irene Cassaniti, et al.
ESMO Open (2023) Vol. 8, Iss. 3, pp. 101215-101215
Open Access | Times Cited: 12
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies
Katy A. Lloyd, Jim Middelburg, Vitalijs Ovcinnikovs, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Katy A. Lloyd, Jim Middelburg, Vitalijs Ovcinnikovs, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Vaccines for preventing infections in adults with solid tumours
Caroline Hirsch, Ana-Mihaela Zorger, Marcus Baumann, et al.
Cochrane library (2025) Vol. 2025, Iss. 4
Closed Access
Caroline Hirsch, Ana-Mihaela Zorger, Marcus Baumann, et al.
Cochrane library (2025) Vol. 2025, Iss. 4
Closed Access
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study
Zoe Quandt, Anastasia Lucas, Samantha Liang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 5, pp. e011545-e011545
Open Access
Zoe Quandt, Anastasia Lucas, Samantha Liang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 5, pp. e011545-e011545
Open Access
Pleiotropic Effects of Influenza Vaccination
Astrid Hjelholt, Cecilia Bergh, Deepak L. Bhatt, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1419-1419
Open Access | Times Cited: 9
Astrid Hjelholt, Cecilia Bergh, Deepak L. Bhatt, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1419-1419
Open Access | Times Cited: 9
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
Angioletta Lasagna, Irene Cassaniti, Francesca Arena, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6731-6731
Open Access | Times Cited: 7
Angioletta Lasagna, Irene Cassaniti, Francesca Arena, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6731-6731
Open Access | Times Cited: 7
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
Vaccination of Adults With Cancer: ASCO Guideline Clinical Insights
Mini Kamboj, Kari Bohlke, Elise C. Kohn
JCO Oncology Practice (2024) Vol. 20, Iss. 7, pp. 889-892
Closed Access | Times Cited: 1
Mini Kamboj, Kari Bohlke, Elise C. Kohn
JCO Oncology Practice (2024) Vol. 20, Iss. 7, pp. 889-892
Closed Access | Times Cited: 1
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience
Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 642-642
Open Access | Times Cited: 1
Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 642-642
Open Access | Times Cited: 1
Immune Checkpoint Inhibitors and Vaccination: Assessing Safety, Efficacy, and Synergistic Potential
Jacob New, Luke M. Shenton, Radia Ksayer, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1270-1270
Open Access | Times Cited: 1
Jacob New, Luke M. Shenton, Radia Ksayer, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1270-1270
Open Access | Times Cited: 1
A systematic review and meta-analysis of e-cigarette use among cancer survivors
María A. López-Olivo, Justin James, Joel James, et al.
Journal of Cancer Survivorship (2023) Vol. 18, Iss. 3, pp. 1059-1074
Closed Access | Times Cited: 2
María A. López-Olivo, Justin James, Joel James, et al.
Journal of Cancer Survivorship (2023) Vol. 18, Iss. 3, pp. 1059-1074
Closed Access | Times Cited: 2
Effectiveness and Safety of COVID-19 Vaccination in Patients with Malignant Disease
Li Zhao, Lin Fu, Yuqin He, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 486-486
Open Access | Times Cited: 1
Li Zhao, Lin Fu, Yuqin He, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 486-486
Open Access | Times Cited: 1
Global burden of vaccine-associated cutaneous immune-related adverse events, 1968–2024: An international pharmacovigilance study
Jaehyeong Cho, Hyesu Jo, Damiano Pizzol, et al.
Life Cycle (2024) Vol. 4
Closed Access
Jaehyeong Cho, Hyesu Jo, Damiano Pizzol, et al.
Life Cycle (2024) Vol. 4
Closed Access
Impact of COVID-19 Pandemic on Frontline Pembrolizumab-Based Treatment for Advanced Lung Cancer
Tawee Tanvetyanon, Dung‐Tsa Chen, Jhanelle E. Gray
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1611-1611
Open Access
Tawee Tanvetyanon, Dung‐Tsa Chen, Jhanelle E. Gray
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1611-1611
Open Access
Data from Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
Data from Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
(2023)
Open Access
